Antitumor efficacy of <sup>90</sup>Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Journal for ImmunoTherapy of Cancer
August 1, 2022
Cited by 32


Related Papers

No related papers found

Powered by citation graph analysis